MDA5+ Dermatomyositis Is Associated with Stronger Skin Type I Interferon Transcriptomic Signature with Upregulation of IFN-κ Transcript-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MDA5+ Dermatomyositis Is Associated with Stronger Skin Type I Interferon Transcriptomic Signature with Upregulation of IFN-κ Transcript

Published:2020-06 Issue:6 Volume:140 Page:1276-1279.e7
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Cassius Charles^ORCID,Amode Reyhan^ORCID,Delord Marc^ORCID,Battistella Maxime^ORCID,Poirot Justine^ORCID,How-Kit Alexandre^ORCID,Lepelletier Clémence^ORCID,Jachiet Marie^ORCID,de Masson Adèle^ORCID,Frumholtz Laure^ORCID,Cordoliani Florence^ORCID,Boccara David^ORCID,Lehmann-Che Jacqueline^ORCID,Wong Jennifer^ORCID,Dubanchet Sylvie^ORCID,Alberdi Antonio José^ORCID,Merandet Marine^ORCID,Bagot Martine^ORCID,Bensussan Armand^ORCID,Bouaziz Jean-David^ORCID,Le Buanec Hélène^ORCID

Funder

Conseil Régional d’Ile-de-France

Canceropôle Ile-de-France

Université Paris-Diderot

Association Saint-Louis

Association Jean-Bernard

Fondation pour la Recherche Médicale

French National Institute for Cancer Research

Ministère de la Recherche

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference18 articles.

1. Dermatomyositis with or without anti-melanoma differentiation-associated gene 5 antibodies: common interferon signature but distinct NOS2 expression;Allenbach;Am J Pathol,2016

2. Type I interferon pathway in adult and juvenile dermatomyositis;Baechler;Arthritis Res Ther,2011

3. Biomarkers in adult dermatomyositis: tools to help the diagnosis and predict the clinical outcome;Cassius;J Immunol Res,2019

4. A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients;Higgs;Ann Rheum Dis,2014

5. Anti-melanoma differentiation–associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features;Kurtzman;J Am Acad Dermatol,2018

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalised medicine in juvenile dermatomyositis: From novel insights in disease mechanisms to changes in clinical practice;Best Practice & Research Clinical Rheumatology;2024-08

2. Decoding the genetic landscape of juvenile dermatomyositis: insights from phosphorylation-associated single nucleotide polymorphisms;Immunogenetics;2024-07-31

3. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study;Journal of Autoimmunity;2024-07

4. Effectiveness of generic tofacitinib in idiopathic inflammatory myositis (IIM)—a retrospective analysis from Indian Myositis Registry (MyoIN);Clinical Rheumatology;2024-06-03

5. Idiopathic inflammatory myopathies: current insights and future frontiers;The Lancet Rheumatology;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3